Toggle navigation
Home
Search
Services
Blog
Contact
About
Preclinical Efficacy and Intermediate Endpoint Assays
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Immunomodulation During Pulmonary Cryptococcosis
Mechanistic Studies on Viral Assembly
Hyperinsulimemia and Endothelin Excretion
Plasma Ethanol Concentration and Behavior
I-Corps: An integrated wide-area unmanned aerial vehicle (UAV) aeromagnetic survey system targeting orphaned oil and gas wells
Recently added grants:
'Two year outcomes after dextrose gel prophylaxis for neonatal hypoglycaemia'
Basic and Clinical Studies in Reinforcing Positive Behaviors in Intellectual and Developmental Disabilities
Molecular and Vascular MRI of Placenta Accreta
Applying Diffusion Basis Spectrum Imaging to Characterize Human Placenta Immuno-response during normal term and preterm pregnancies
Molecular Regulation of Atherosclerosis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN53300-4-0-1
Application #
7587180
Study Section
Project Start
2005-08-15
Project End
2009-08-14
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Preclinical Efficacy and Intermediate Endpoint Assays
/ University of Oklahoma Health Sciences Center
$1,535,783
NIH 2007
N01 CA
Preclinical Efficacy and Intermediate Endpoint Assays
Roa, C. /
$1,444,000
NIH 2007
N01 CA
Preclinical Efficacy and Intermediate Endpoint Assays
/
Comments
Be the first to comment on this grant